Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
3.579 EUR | -0.33% | +6.11% | -24.17% |
Mar. 26 | Valneva Kicks Off Early-stage Trial for Zika Vaccine Candidate | MT |
Mar. 26 | Valneva: Phase 1 trial initiated in the Zika virus | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.17% | 539M | |
+9.16% | 45.97B | |
+53.58% | 43.93B | |
+11.20% | 42.34B | |
-8.59% | 28.27B | |
+16.40% | 27.18B | |
-19.34% | 19.44B | |
+13.95% | 13.83B | |
+31.56% | 12.4B | |
+10.63% | 11.45B |
- Stock
- Equities
- Stock Valneva - Euronext Paris
- News Valneva
- Health Care Stocks Rising Wednesday, Helping Keep Broader Markets Near Positive Ground